Clinical Evaluation of Human Papillomavirus Detection by careHPVTM Test on Physician-Samples and Self-Samples using The Indicating FTA Elute® Card |
Wang, Shao-Ming
(National Cancer Center & Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College)
Hu, Shang-Ying (National Cancer Center & Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College) Chen, Feng (National Cancer Center & Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College) Chen, Wen (National Cancer Center & Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College) Zhao, Fang-Hui (National Cancer Center & Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College) Zhang, Yu-Qing (National Cancer Center & Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College) Ma, Xin-Ming (National Cancer Center & Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College) Qiao, You-Lin (National Cancer Center & Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College) |
1 | Arbyn M, Ronco G, Anttila A, et al (2012). Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine, 30, 88-99. DOI |
2 | Gage JC, Ajenifuja KO, Wentzensen N, et al (2012). Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria. Int J Cancer, 131, 2903-9. DOI |
3 | Gonzalez P, Cortes B, Quint W, et al (2012). Evaluation of the FTA carrier device for human papillomavirus testing in developing countries. J Clin Microbiol, 50, 3870-6. DOI |
4 | Guan Y, Castle PE, Wang S, et al (2012). A cross-sectional study on the acceptability of self-collection for HPV testing among women in rural China. Sex Transm Infect, 88, 490-4. DOI |
5 | Guan Y, Gravitt PE, Howard R, et al (2013). Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens. J Virol Methods, 189, 167-71. DOI |
6 | Gustavsson I, Lindell M, Wilander E, et al (2009). Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. J Clin Virol, 46, 112-6. DOI |
7 | Gustavsson I, Sanner K, Lindell M, et al (2011). Type-specific detection of high-risk human papillomavirus (HPV) in selfsampled cervicovaginal cells applied to FTA elute cartridge. J Clin Virol, 51, 255-8. DOI |
8 | IARC (2005). Cervix Cancer Screening IARC Handbooks of Cancer Prevention 10. |
9 | Kang LN, Jeronimo J, Qiao YL, et al (2014). Optimal positive cutoff points for careHPV testing of clinician- and selfcollected specimens in primary cervical cancer screening: an analysis from rural China. J Clin Microbiol, 52, 1954-61. DOI |
10 | Lenselink CH, de Bie RP, van Hamont D, et al (2009). Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening. J Clin Microbiol, 47, 2564-70. DOI |
11 | Phongsavan K, Gustavsson I, Marions L, et al (2012). Detection of human papillomavirus among women in Laos: feasibility of using filter paper card and prevalence of high-risk types. Int J Gynecol Cancer, 22, 1398-406. DOI |
12 | Qiao YL, Sellors JW, Eder PS, et al (2008). A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol, 9, 929-36. DOI ScienceOn |
13 | Ronco G, Dillner J, Elfstrom KM, et al (2014). Efficacy of HPVbased screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet, 383, 524-32. DOI |
14 | Sankaranarayanan R, Esmy PO, Rajkumar R, et al (2007). Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet, 370, 398-406. DOI ScienceOn |
15 | Yoshida T, Nishijima Y, Hando K, et al (2013). Primary study on providing a basic system for uterine cervical screening in a developing country: analysis of acceptability of selfsampling in Lao PDR. Asian Pac J Cancer Prev, 14, 3029-35. DOI |
16 | Zhang SK, Ci PW, Velicer C, et al (2014). Comparison of HPV genotypes and viral load between different sites of genital tract: the significance for cervical cancer screening. Cancer Epidemiol, 38, 168-73. DOI |
17 | Zhao FH, Lin MJ, Chen F, et al (2010). Performance of highrisk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol, 11, 1160-71. DOI ScienceOn |